Suzanne Luck
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Epidemiology top 1%
- Cytomegalovirus and herpesvirus research
- Sepsis Diagnosis and Treatment
Papers in
- Epidemiology 28
- Cytomegalovirus and herpesvirus research 26
- Sepsis Diagnosis and Treatment 1
-
- COVID-19 Clinical Research Studies 10
- Co-authors
- Mike Sharland (20 shared papers)P. D. Griffiths (15 shared papers)Rana Chakraborty (3 shared papers)Seilesh Kadambari (12 shared papers)Eleri Williams (5 shared papers)Claire E. Atkinson (8 shared papers)Paul Trafford Heath (6 shared papers)Daniel Blázquez‐Gamero (2 shared papers)
- Journals
- The Lancet (9 papers)Archives of Disease in Childhood Fetal & Neonatal (5 papers)Archives of Disease in Childhood (4 papers)The Pediatric Infectious Disease Journal (2 papers)Journal of Clinical Virology (2 papers)
- Partner nations
- United KingdomSpainAustralia
In The Last Decade
Suzanne Luck
45 papers receiving 5.1k citations
Suzanne Luck's Hit Papers
Peers
Comparison fields: 5 of 106
- Infectious Diseases 2.4k
- Epidemiology 1.7k
- Applied Microbiology and Biotechnology 73
- Sensory Systems 58
- Internal Medicine 31
Countries citing papers authored by Suzanne Luck
This map shows the geographic impact of Suzanne Luck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Luck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Luck more than expected).
Fields of papers citing papers by Suzanne Luck
This network shows the impact of papers produced by Suzanne Luck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Luck. The network helps show where Suzanne Luck may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne Luck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 1531 |
| 2 | Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease Hit paper breakdown → | 2015 | 614 |
| 3 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 4 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 5 | 2011 | 339 | |
| 6 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 7 | 2017 | 234 | |
| 8 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 9 | 2021 | 213 | |
| 10 | 2003 | 99 | |
| 11 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 12 | 2020 | 77 | |
| 13 | 2011 | 75 | |
| 14 | 2014 | 68 | |
| 15 | 2020 | 67 | |
| 16 | 2008 | 57 | |
| 17 | 2015 | 51 | |
| 18 | 2009 | 48 | |
| 19 | 2018 | 39 | |
| 20 | 2016 | 36 |
About Suzanne Luck
Suzanne Luck is a scholar working on Epidemiology, Infectious Diseases, Physiology, Public Health, Environmental and Occupational Health and Applied Microbiology and Biotechnology, having authored 45 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (26 papers), COVID-19 Clinical Research Studies (10 papers), Neonatal and Maternal Infections (3 papers), Syphilis Diagnosis and Treatment (3 papers), Kawasaki Disease and Coronary Complications (1 paper), Bacterial Infections and Vaccines (1 paper), Sepsis Diagnosis and Treatment (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Infectious Diseases (2.4k citations), Epidemiology (1.7k citations), Applied Microbiology and Biotechnology (73 citations), Sensory Systems (58 citations) and Internal Medicine (31 citations). Suzanne Luck has collaborated with scholars based in United Kingdom, Spain and Australia. Frequent co-authors include Mike Sharland, P. D. Griffiths, Rana Chakraborty, Seilesh Kadambari, Eleri Williams, Claire E. Atkinson, Paul Trafford Heath, Daniel Blázquez‐Gamero, Simone Walter and Janet Elizabeth Berrington. Their work appears in journals such as The Lancet, Archives of Disease in Childhood Fetal & Neonatal, Archives of Disease in Childhood, The Pediatric Infectious Disease Journal and Journal of Clinical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.